Organization Overview
Alternative names
fludeoxyglucose f-18 (1994 NDA)
Acne Vulgaris (Phase 4)
Anemia (Phase 3)
Anemia, Sickle Cell (Phase 3)
Apnea (Phase 2)
Asthma (Phase 2)
Autism Spectrum Disorder (Phase 2)
Autistic Disorder (Phase 2)
Child Development Disorders, Pervasive (Phase 2)
Disease (Phase 2)
Dysmenorrhea (Phase 3)
Dyspareunia (Phase 3)
Endometriosis (Phase 3)
Hematologic Diseases (Phase 3)
Hemoglobinopathies (Phase 3)
Hypertension (Phase 4)
Insulin Resistance (Phase 4)
Kidney Diseases (Phase 4)
Kidney Failure, Chronic (Phase 4)
Language Disorders (Phase 2)
Multiple Myeloma (Phase 3)
Nasal Polyps (Phase 3)
Neoplasms, Plasma Cell (Phase 3)
Pain, Postoperative (Phase 4)
Panic Disorder (Phase 2)
Pneumonia (Phase 3)
Pruritus (Phase 2)
Psoriasis (Phase 2)
Renal Insufficiency, Chronic (Phase 4)
Retinopathy of Prematurity (Phase 2)
Rhinitis (Phase 2)
Rhinitis, Allergic (Phase 2)
Sleep Apnea, Obstructive (Phase 2)
Sleep Apnea Syndromes (Phase 2)
Syndrome (Phase 2)
Thalassemia (Phase 1)